ViaLase

company

About

ViaLase develops an image-guided femtosecond laser surgical system for the treatment of glaucoma.

  • 1 - 10

Details

Last Funding Type
Series A
Last Funding Money Raised
$27.28M
Industries
Health Care,Medical Device,Wellness
Founded date
Jan 1, 2019
Number Of Employee
1 - 10
Operating Status
Active

ViaLase develops an image-guided femtosecond laser surgical system for the treatment of glaucoma. The company's system focuses on the development of micron-resolution OCT image-guided femtosecond laser technology to create micron-sized customized drainage channels through the trabecular meshwork that connects the anterior chamber to the Schlemm's canal without surgically opening or penetrating the eye, enabling medical professionals to improve glaucoma management with its efficient non-invasive treatment.

ViaLase was incorporated in 2019 and is headquartered in Corona Del Mar, California.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$27.28M
ViaLase has raised a total of $27.28M in funding over 2 rounds. Their latest funding was raised on Nov 19, 2021 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 19, 2021 Series A $27.28M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
ViaLase is funded by 1 investors. Versant Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Versant Ventures Series A